Euronext N.V.

Earnings Release • Aug 8, 2011

CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)

CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)

NYSE Euronext Announces Trading Volumes for July 2011

Global Derivatives ADV Up 13% Year-Over-Year on Strong U.S. Options; Global Cash Equities ADV Mixed; European Cash ADV Up 16%, U.S. Cash Down 24% NYSE Liffe U.S. Total Open Interest Over 800,000 Contracts

August 8, 2011 – NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for July 2011¹ . Global derivatives average daily volume ("ADV") of 8.0 million contracts in July 2011 increased 12.6% versus the prior year driven by a 33.7% increase in U.S. options ADV partially offset by a 6.2% decrease in European derivatives. Cash equities ADV in July 2011 was mixed, with European cash ADV increasing 15.8% and U.S. cash trading ADV decreasing 23.9% from July 2010 levels.

Highlights

• NYSE Euronext global derivatives ADV in July 2011 of 8.0 million contracts increased 12.6% compared to July 2010, but decreased 10.0% from June 2011 levels.
• NYSE Euronext European derivatives products ADV in July 2011 of 3.7 million contracts decreased 6.2% compared to July 2010 and decreased 19.9% from June 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 3.0% compared to July 2010 and decreased 10.2% from June 2011 and is running 7.6% below second quarter 2011 levels.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.1 million contracts in July 2011 increased 33.7% compared to July 2010 levels and increased 0.9% from June 2011. NYSE Euronext's U.S. options exchanges accounted for 25.8% of total U.S. consolidated equity options trading in July 2011, up slightly from 25.3% in July 2010, but down from 26.4% recorded in June 2011.
• NYSE Liffe U.S. ADV of approximately 101,300 contracts represented an increase of 760.3% compared to July 2010 and an increase of 3.8% compared to June 2011. Since the launch of NYSE Liffe U.S. interest rate products in March 2011, 6.8 million contracts have been traded and open interest is over 700,000 contracts. Total exchange open interest is now over 800,000 contracts.
• NYSE Euronext European cash products ADV of 1.6 million transactions in July 2011 increased 15.8% compared to July 2010 and increased 8.0% from June 2011 levels.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.0 billion shares in July 2011 decreased 23.9% compared to July 2010 and decreased 7.4% compared to June 2011. NYSE Euronext's Tape A matched market share in July 2011 was 34.3%, down from 37.6% in July 2010 and down from 36.6% in June 2011.

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

• There were a total of 21 trading days in Europe and 20 trading days in the U.S. in July 2011 compared to 22 trading days in Europe and 21 trading days in the U.S. in July 2010.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in July 2011 was 3.7 million futures and options contracts, a decrease of 6.2% from July 2010 and a decrease of 19.9% from June 2011.
• The 3.7 million in European derivatives futures and options contracts ADV in July 2011 consisted of 2.9 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.8 million contracts, or 21.1%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV decreased 2.9% compared to July 2010 and decreased 10.2% from June 2011.
• Year-to-date, European derivatives products ADV of 4.8 million contracts was 12.6% below prior year levels. The 4.8 million in futures and options contracts ADV year-todate consisted of 3.4 million contracts executed through LIFFE CONNECT trading platform and 1.4 million contracts, or 28.2%, executed through Bclear.
• Total fixed income products ADV of 1.9 million contracts in July 2011 decreased 5.2% from July 2010 and decreased 13.0% from June 2011. Year-to-date, total fixed income products ADV of 2.3 million contracts was 9.2% below prior year levels.
• Total equity products (including Bclear) ADV of 1.8 million contracts in July 2011 decreased 7.2% compared to July 2010 and decreased 26.3% from June 2011. The 1.8 million contracts in equity products ADV consisted of 1.2 million contracts in individual equity products ADV and 0.6 million contracts in equity index products ADV. The 1.2 million contracts in individual equity products ADV consisted of 0.7 million in futures contracts, which represented a 19.0% decrease compared to July 2010 and 0.5 million in options contracts, which represented a 2.2% increase compared to July 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.4 million contracts was 17.0% below prior year levels.
• Total commodities products ADV of 78,000 contracts in July 2011 decreased 8.3% compared to July 2010 and decreased 16.5% compared to June 2011. Year-to-date, total commodities product ADV of 85,000 contracts was 45.8% above prior year levels.
• U.S. Derivatives
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.1 million contracts in July 2011 increased 33.7% compared to July 2010 and increased 0.9% compared to June 2011. Year-to-date, U.S. equity options ADV of 4.2 million contracts was 11.5% above prior year levels.
• Total U.S. consolidated equity options ADV increased 31.0% to 16.0 million contracts in July 2011 compared to July 2010 and increased 3.0% compared to June 2011. Year-todate, U.S. consolidated equity options ADV of 16.5 million contracts was 13.6% above prior year levels.
• NYSE Euronext's U.S. options exchanges accounted for 25.8% of the total U.S. consolidated equity options trading in July 2011, up slightly from 25.3% in July 2010, but down from 26.4% in June 2011.
• NYSE Liffe U.S. ADV of approximately 101,300 contracts represented an increase of 760.3% compared to July 2010 and an increase of 3.8% compared to June 2011. Since the launch of NYSE Liffe U.S. interest rate products in March 2011, 6.8 million contracts have

been traded and open interest is over 700,000 contracts. Total exchange open interest is now over 800,000 contracts. Year-to-date, U.S. futures and futures options ADV of 63,400 contracts was 242.6% above prior year levels.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.6 million transactions in July 2011 increased 15.8% compared to July 2010 and increased 8.0% compared to June 2011.
• Year-to-date, European cash products ADV of 1.7 million transactions was 9.3% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in July 2011 decreased 23.9% to 2.0 billion shares compared to July 2010 and decreased 7.4% from June 2011.
• Year-to-date, U.S. cash products handled ADV was 2.2 billion shares, down 24.0% from prior year levels.
• NYSE Euronext's Tape A matched market share in July 2011 was 34.3%, down from 37.6% in July 2010 and down from 36.6% in June 2011.

Exchange Traded Funds

• NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 277 million shares in July 2011 decreased 17.8% compared to July 2010 and decreased 5.2% compared to June 2011.
• Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 280 million shares was 23.8% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Safe Harbour Statement

In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding N.V. ("Holding"), a newly formed holding company, filed, and the SEC declared effective on May 3, 2011, a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission ("SEC") that includes (1) a proxy statement of NYSE Euronext that also constitutes a prospectus for Holding which was used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding's offer to acquire Deutsche Boerse AG shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) ("BaFin"), which was approved by the BaFin for publication pursuant to

the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011.

Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC's website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext's website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding's website at www.global-exchange-operator.com.

This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.

No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.

Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer will not be made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.

The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.

	Average Daily Volume			Total Volume			Average Daily Volume		Total Volume
(Unaudited; contracts in thousands)	Jul-11	Jul-10	% Chg	Jul-11	Jul-10	% Chg	YTD 2011	% Chg vs. YTD 2010	YTD 2011	% Chg vs. YTD 2010
Number of Trading Days - European Markets Number of Trading Days - U.S. Markets	21 20	22 21		21 20	22 21		148 145		148 145
European Derivatives Products	3,711	3,957	-6.2%	77,933		87,052 -10.5%	4,784	-12.6%	707,984	-12.6%
of which Bclear	783		940 -16.7%	16,448		20,680 -20.5%	1,349	-19.8%	199,657	-19.8%
Total Fixed Income Products	1,881	1,984	-5.2%	39,500	43,640	-9.5%	2,348	-9.2%	347,523	-9.2%
Short Term Interest Rate Products Medium and Long Term Interest Rate Products 1	1,755 126	1,895 89	-7.4% 42.4%	36,848 2,652	1,952	41,688 -11.6% 35.9%	2,213 135	-10.4% 17.2%	327,566 19,957	-10.4% 17.2%
Total Equity Products 2	1,752	1,888	-7.2%	36,798		41,543 -11.4%	2,351	-17.0%	347,888	-17.0%
Individual Equity Products	1,207		1,350 -10.6%	25,351		29,699 -14.6%	1,798	-17.7%	266,064	-17.7%
Futures Options	659 549	537	813 -19.0% 2.2%	13,830 11,521	11,815	17,884 -22.7% -2.5%	1,186 611	-18.3% -16.7%	175,578 90,487	-18.3% -16.7%
Equity Index Products	545	538	1.3%	11,447	11,844	-3.4%	553	-14.4%	81,823	-14.4%
of which Bclear	783		940 -16.7%	16,448		20,680 -20.5%	1,349	-19.8%	199,657	-19.8%
Individual Equity Products Futures	725 639		881 -17.7% 799 -20.0%	15,218 13,415		19,380 -21.5% 17,577 -23.7%	1,275 1,171	-19.3% -19.2%	188,694 173,280	-19.3% -19.2%
Options	86	82	4.8%	1,803	1,803	0.0%	104	-20.1%	15,414	-20.1%
Equity Index Products	59	59	-0.9%	1,230	1,299	-5.4%	74	-27.8%	10,963	-27.8%
Commodity Products	78	85	-8.3%	1,636		1,869 -12.5%	85	45.8%	12,574	45.8%
U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts Total Consolidated Options Contracts	4,141 16,039	3,096 12,241	33.7% 31.0%	82,814 320,788 257,061	65,015	27.4% 24.8%	4,218 16,459	11.5% 13.6%	611,552 2,386,559	11.5% 13.6%
NYSE Group Share of Total	25.8%	25.3%		25.8%	25.3%		25.6%	-0.5%	25.6%	-0.5%
NYSE Liffe U.S.
Futures and Futures Options Volume*	101.3		11.8 760.3%	2,127		247 760.3%	63.4	242.6%	9,451.7	252.0%
European Cash Products (trades in thousands)	1,640	1,416	15.8%	34,432	31,144	10.6%	1,668	9.3%	246,809	9.3%
Equities	1,578		1,364 15.7%	33,148		30,004 10.5%	1,604	9.4%	237,339	9.4%
Exchange-Traded Funds	19		16 15.5%	389		353 10.3%	18	0.4%	2,736	0.4%
Structured Products Bonds	38 5	5	31 21.8% 0.8%	797 98	102	685 16.3% -3.8%	40 5	11.9% -13.8%	5,968 765	11.9% -13.8%
U.S. Cash Products (shares in millions) 5	1,993	2,620	-23.9%	39,857 55,015		-27.6%	2,164	-24.0%	313,793	-24.0%
NYSE Listed (Tape A) Issues 4
Handled Volume 5	1,382	1,894	-27.0%	27,640	39,773	-30.5%	1,539	-25.8%	223,109	-25.8%
Matched Volume 6	1,310	1,779	-26.3%	26,208	37,353	-29.8%	1,457	-24.8%	211,230	-24.8%
Total NYSE Listed Consolidated Volume	3,822	4,728	-19.2%	76,447	99,294	-23.0%	4,190	-21.7%	607,568	-21.7%
Share of Total Consolidated Volume
Handled Volume 5 Matched Volume 6	36.2% 34.3%	40.1% 37.6%	-3.9% -3.3%	36.2% 34.3%	40.1% 37.6%	-3.9% -3.3%	36.7% 34.8%	-2.0% -1.4%	36.7% 34.8%	-2.0% -1.4%
NYSE Arca & Amex (Tape B) Listed Issues
Handled Volume 5 Matched Volume 6	326 294	377 341	-13.7% -13.7%	6,517 5,878	7,927 7,155	-17.8% -17.8%	339 304	-20.4% -19.9%	49,092 44,124	-20.4% -19.9%
Total NYSE Arca & Amex Listed Consolidated Volume	1,273	1,412	-9.8%	25,465	29,649	-14.1%	1,313	-19.1%	190,328	-19.1%
Share of Total Consolidated Volume
Handled Volume 5 Matched Volume 6	25.6%	26.7%	-1.1%	25.6%	26.7%	-1.1%	25.8%	-0.4%	25.8%	-0.4%
Nasdaq Listed (Tape C) Issues	23.1%	24.1%	-1.0%	23.1%	24.1%	-1.0%	23.2%	-0.2%	23.2%	-0.2%
Handled Volume 5	285	348	-18.2%	5,701	7,314	-22.1%	287	-18.0%	41,593	-18.0%
Matched Volume 6	246	297	-17.2%	4,914	6,231	-21.1%	244	-16.3%	35,410	-16.3%
Total Nasdaq Listed Consolidated Volume	1,891	2,108	-10.3%	37,811	44,266	-14.6%	2,005	-16.0%	290,721	-16.0%
Share of Total Consolidated Volume
Handled Volume 5 Matched Volume 6	15.1% 13.0%	16.5% 14.1%	-1.4% -1.1%	15.1% 13.0%	16.5% 14.1%	-1.4% -1.1%	14.3% 12.2%	-0.3% 0.0%	14.3% 12.2%	-0.3% 0.0%
Exchange-Traded Funds 5,7
Handled Volume 5	308	374	-17.7%	6,150	7,850	-21.7%	311	-24.0%	45,153	-24.0%
Matched Volume 6	277	337	-17.8%	5,539	7,080	-21.8%	280	-23.8%	40,549	-23.8%
Total ETF Consolidated Volume	1,231	1,422	-13.4%	24,614	29,853	-17.6%	1,228	-23.5%	178,078	-23.5%
Share of Total Consolidated Volume Handled Volume 5	25.0%	26.3%	-1.3%	25.0%	26.3%	-1.3%	25.4%	-0.2%	25.4%	-0.2%
Matched Volume 6	22.5%	23.7%	-1.2%	22.5%	23.7%	-1.2%	22.8%	0.0%	22.8%	0.0%

7 Data included in previously identified categories.

* ADVs calculated with the appropriate number of NYSE Liffe U.S. trading.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

4 Includes all volume executed in NYSE Group crossing sessions.

NYSE Euronext Monthly Volume Summary

6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

1 Data includes currency products.

2 Includes Bclear trading Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

3 Includes trading in U.S. equity options contracts, not equity-index options.